Cardiology

Study results suggest that antihyperglycemic agents are too often inappropriately discontinued after hospitalization for type 2 diabetes mellitus, possibly to the detriment of patients.

Current treatment for fibromuscular dysplasia mainly includes symptom management rather than treating the overall condition. Research is working to find not only the cause of the condition but a more robust treatment option.

In a time when doctors are busier than ever and patients still want to feel a personal connection to their health care professionals, finding new ways to have that balance has become a field of study for now and the future.

In the changing landscape of hospital medicine one of the largest areas of focus has been on readmission rates, this is also true for patients who are discharged from one hospital and then readmitted into another location for further treatment.

There may be a wealth of options available for patients with heart failure but work is continually being done to find new and better treatment options.

Finding a way to treat acute kidney injury has been no easy task for the medical community. Now researchers are looking at whether a patient's own cells could be the key to providing the treatment they need.

As one of the fastest growing economies in the world China is also dealing with one of the largest pollution problems across the world. What can be done to address those issues on a permanent basis is the study of a recent study by researchers around the globe.

Seniors who developed the painful rash commonly known as shingles may also be at higher risk of suffering a stroke or heart attack.

From cardiologists to physical therapists to nurses there is a team approach needed to provide cardiac patients the care they need for treatment. Keeping that care going even after a cardiac event has passed has been a growing focus of the field in recent years.

People who take a common drug for type 2 diabetes may be at risk for serious drug interactions if they add the blood thinner warfarin to the mix.

Not only do women with type 2 diabetes have double the risk of cardiovascular disease compared with men, but they also need more frequent and intense physical activity to lower that risk.

A powerful new drug discovery technique may have uncovered a candidate compound for treating type 2 diabetes.

For many years patients with heart failure were ineligible to be reimbursed for cardiac rehabilitation for their condition. Those guidelines have now changed for many patients showing impressive benefits from the work.

Rehospitalization is becoming a growing concern in the health care field with health systems facing financial consequences if they do not reach certain benchmarks. A recent study of an approved medication showed benefits in this area that could help patients and providers alike.

A considerable amount of research has been done into the neurological issues facing football players but work is also being done to study the impact on the heart of some of the larger players on the field as well.

A trio of professional societies has issued consensus recommendations for the use of left atrial appendage closure devices recommendations that argue against several significant restrictions in proposed rules from the Centers for Medicare and Medicaid Services.

There are medications currently available to help patients diagnosed with heart failure but many do not address quality of life of these patients after treatment. A new medication being investigated could help with both issues of patient care.

When treatment of cardiovascular disease goes beyond the heart and into other areas of the body it can present different challenges for cardiologists. Finding new ways to overcome those challenges has been a focus of many conditions including peripheral artery disease.

As more research is done into the effects of Brilinta on patients more is learned about new ways doctors can prescribe the medication to help their patients.

When people think of digital health aids they may not think beyond their smartphone or other wearable devices. Work is being done to move this field in a direction even more helpful than currently used.

It was not that long ago that PCSK9 inhibitors were just an idea being discussed in the field of cardiology. Just a few months ago the FDA approved the first treatments which has meant answers to many questions with some questions still remaining.

Nonalcoholic fatty liver disease (NAFLD) is now the most common hepatic pathology in developed nations. Public health officials are worried, as NAFLD increases the likelihood of diabetes, cardiovascular disease and chronic kidney disease.

The contrast media injected into patients' vascular systems in a heart procedure can cause injuries to the kidneys. That is particularly true for patients with chronic kidney disease. Diluting the effect by hydrating a patient helps, but can risk overloading the heart. Chinese doctors offer a solution.

Part of an ongoing series that takes a high-level look at the positions of the leading nominees for President when it comes to political issues potentially impacting physicians, this installment focuses on Donald Trump.

A new treatment option for deep vein thrombosis (DVT) and pulmonary embolism (PE) was recently introduced, but it looks like old habits die hard when it comes to prescriptions.

Ventricular assist devices (VADs) are literally life savers for some patients with heart failure, however, the technology can be accompanied by serious risks.

There are pros and cons to giving patients once-weekly injections of glucagon-like peptide-1 receptor agonists (GLP-1RAs), a new group of drugs to treat type 2 diabetes.

Older patients with heart and kidney failure can be helped with cardiac resynchronization therapy, a new study finds. But implanting devices to treat them is expensive, invasive, and not a full cure for many patients. Maybe it's better to ask these patients if they wouldn't rather die, two physicians argue.

Sudden unexpected death in epilepsy (SUDEP) is poorly understood. In research presented at the American Epilepsy Society 69th Annual Meeting in Philadelphia, there is new evidence that mutations in genes that control heart rhythm may explain some cases.

When a medical condition is paired with another, it could make for a trickier situation. New research found that some diseases can significantly impact platelet function while others appear to have no effect.